Assistant Professor WATANABE, Hiroaki
Faculty, Affiliation
Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences
College and School Educational Field
Laboratory
Academic Background
Career
Kanazawa University Institute of Medical, Pharmaceutical and Health Sciences Faculty of Pharmacy Assistant professor(2025/04-)
Shinshu University Shinshu University Hospital Division of Pharmacy(2021/10-2025/03)
Shinshu University Shinshu University Hospital Division of Pharmacy(2020/04-2021/09)
Shinshu University Shinshu University Hospital Division of Pharmacy Pharmacist(2014/04-2020/03)
Year & Month of Birth
Academic Society
Award
Specialities
Medical pharmacy
Speciality Keywords
Research Themes
Development of Biomarkers Based on Evaluation of Individual Variability Factors Aimed at Optimizing CDK4/6 Inhibitor Administration Methods
Development of Biomarkers Based on Evaluation of Individual Variability Factors Aimed at Optimizing PARP Inhibitor Administration Methods
Analysis of the Relationship Between CARG Score and Intensity of Cancer Chemotherapy Treatment
Books
Papers
- Day 8 monocyte and lymphocyte counts as a novel and early predictor for discontinuation in gynecologic cancer patients receiving paclitaxel and carboplatin therapy: a retrospective observational study. Hiroaki Watanabe,Keita Hirai,Hirofumi Komachiya,Takafumi Naito Journal of pharmaceutical health care and sciences 2026/02/04
- [Current Status of Cancer Genomic Profiling Test in Shinshu University Hospital] Mariko Miyagawa,Shintaro Kanda,Shohei Shigeto,Tomoyuki Nakajima,Yayoi Yamazaki,Hisashi Tamada,Shiho Asaka,Takeshi Uehara,Ayako Tateishi,Hiroaki Watanabe,Hanako Momose,Mayumi Tokoro,Tomomi Kojima,So Nagai,Kyoko Takano,Tomoki Kosho,Tomonobu Koizumi Shinshu-ishi : The Shinshu Medical Journal 72 3 141 2024/06/10
- Effect of Enoxaparin and Daikenchuto Coadministration on Hepatic Disorder Markers in Gynecological Cancer Patients after Abdominal Surgery Hiroaki Watanabe,Keita Hirai,Yuka Nakazawa,Ayaka Koike,Hiroyuki Tsuchiya,Takafumi Naito Biological and Pharmaceutical Bulletin 47 4 758 2024/04/02
- In Vitro Inhibitory Effects of Sesamin on CYP4F2 Activity Hiroaki Watanabe,Satoshi Yamaori,Shinobu Kamijo,Kaori Aikawa,Shigeru Ohmori Biological and Pharmaceutical Bulletin 43 4 688 2020/04/01
- [Desensitization Therapy for Osimertinib in Patients Who Developed Toxic Erythema - Two Case Reports] Hiroaki Watanabe,Akira Mimura,Toshiro Fukushima,Takuro Noguchi,Takesumi Ozawa,Takashi Kobayashi,Nodoka Sekiguchi,Shigeru Ohmori,Tomonobu Koizumi Gan to kagaku ryoho : Japanese Journal of Cancer and Chemotherapy 46 5 961 2019/05/15
Conference Presentations
- Effects of genetic polymorphisms and enzyme activity of CYP3A on the pharmacokinetics of abemaciclib in breast cancer patients(2024/10/03)
Others
Arts and Fieldwork
Patent
Theme to the desired joint research
Grant-in-Aid for Scientific Research
○Grant-in-Aid for Early-Career Scientists「Development of Biomarkers Based on Evaluation of Individual Variability Factors Aimed at Optimizing CDK4/6 Inhibitor Administration Methods」(2024-2026)
○Grant-in-Aid for Encouragement of Scientists「Elucidation of the Mechanism of CYP4F2 Inhibition by HMG-CoA Reductase Inhibitors」(2017-2017)
Competitive research funding,Contribution
○Identification of Liver-Derived Exosome-Contained miRNAs for Early Detection of Drug-Induced Liver Injury by CDK4/6 Inhibitors and Analysis of Their Relationship with Circulating miRNAs(2025-2027)